Tomáš Skácel

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

Petr Zatloukal, Luboš Petruželka, Milada Zemanová et al. · Lung Cancer · 2003 · 162 citations

Medicine, Oncology, Pharmacology +14

Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study

Gϋnter von Minckwitz, Sherko Kümmel, Andreas du Bois et al. · Annals of Oncology · 2007 · 150 citations

Medicine, Oncology, Pharmacology +10

Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis

Sibylle Loibl, Tomáš Skácel, Valentina Nekljudova et al. · BMC Cancer · 2011 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial

Karim Fizazi, Linda D. Bosserman, Guozhi Gao et al. · The Journal of Urology · 2012 · 111 citations

Medicine, Pharmacology, Pharmacotherapy +17